{
    "abstract": "Wenjing Huoxue Decoction (WJHXD) is a traditional treatment for primary dysmenorrhea (PD) that can quickly relieve various symptoms caused by PD. Previous clinical studies have shown that WJHXD has better long-term efficacy than ibuprofen in the treatment of PD and can reverse the disorder of T cell subsets.\nTo investigate the effect of WJHXD on serum-related factors in the treatment of PD, including the identification of key targets, pathways, and active ingredients.\nIn order to study the effects of the WJHXD intervention in Parkinson's Disease (PD) rats, we used transcriptomics and metabolomics methods to examine the differentially expressed genes (DEGs) and differentially expressed metabolites (DEMs). We also utilized network pharmacology to predict the target and effective route of WJHXD in treating PD. Finally, we employed molecular docking (MD) technology to confirm the placement of important targets and metabolites.\nWJHXD has been found to be effective in prolonging the onset time and decreasing the number of writhing episodes in PD rats after oxytocin injection. It has also been observed to reduce the levels of PGF2, COX-2, AVP, and PGE2 in the serum of PD rats to different degrees. Transcriptomics analysis has revealed that the core targets of WJHXD include KRT1, KRT16, CCL5, F2, NOS2, RAC2, and others, while the core pathways are Calcium signaling and cAMP signaling. The Estrogen signaling pathway was found to be downregulated in PD rats compared to normal uterine tissue, but WJHXD was able to up-regulate the pathway. A combined transcriptomics and metabolomics analysis suggested that WJHXD may be involved in eight metabolism-related pathways, with the most reliable ones being mucin-type O-glycan biosynthesis and glycolysis or gluconeogenesis. MD has shown that Hydroxyisocaproic acid may bind to important targets such as SLC6A4, PTGER3, IGFBP3, and IGF2.\nIn WJHXD, the most targeted herbs were Corydalis rhizoma, licorice, and Myrrha. The most targeted active ingredients include quercetin, 3'-Hydroxy-4'-O-methylglabridin, shinpterocarpin, and isorhamnetin. Potential targets include PTGS2, NOS2, AR, SCN5A, and GAS6. Analysis revealed 72 highly reliable relationships between group A and B DEGs and DEMs, with 23 positive correlations and 49 negative correlations among them. A combined analysis of transcriptomics, metabolomics, and network pharmacology was used to identify possible targets, pathways, and active ingredients of WJHXD in PD treatment, and the correlation between DEGs and DEMs was investigated. However, further research is required to confirm the relationship between active ingredients, targets, and metabolites.",
    "authors": [
        {
            "affiliation": "First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Lixia District, Jinan City, Shandong Province 250013, China.",
            "firstname": "Weisen",
            "initials": "W",
            "lastname": "Fan"
        },
        {
            "affiliation": "Institute of Health, Shandong University of Traditional Chinese Medicine, Lixia District, Jinan City, Shandong Province 250013, China.",
            "firstname": "Dandan",
            "initials": "D",
            "lastname": "Wang"
        },
        {
            "affiliation": "Department of Proctology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Lixia District, Jinan City, Shandong 250013, China.",
            "firstname": "Liwei",
            "initials": "L",
            "lastname": "Yan"
        },
        {
            "affiliation": "Department of Gynecology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Lixia District, Jinan City, Shandong 250013, China.",
            "firstname": "Zheng",
            "initials": "Z",
            "lastname": "Yuan"
        }
    ],
    "conclusions": "In WJHXD, the most targeted herbs were Corydalis rhizoma, licorice, and Myrrha. The most targeted active ingredients include quercetin, 3'-Hydroxy-4'-O-methylglabridin, shinpterocarpin, and isorhamnetin. Potential targets include PTGS2, NOS2, AR, SCN5A, and GAS6. Analysis revealed 72 highly reliable relationships between group A and B DEGs and DEMs, with 23 positive correlations and 49 negative correlations among them. A combined analysis of transcriptomics, metabolomics, and network pharmacology was used to identify possible targets, pathways, and active ingredients of WJHXD in PD treatment, and the correlation between DEGs and DEMs was investigated. However, further research is required to confirm the relationship between active ingredients, targets, and metabolites.",
    "copyrights": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.",
    "doi": "10.2174/0113816128295774240523062258\n10.1007/978-981-13-1756-9_16\n10.1097/AOG.0000000000004096\n10.1016/j.pcl.2016.11.004\n10.26355/eurrev_202301_30869\n10.1093/humupd/dmv039\n10.1016/j.ajog.2017.08.108\n10.26355/eurrev_202207_29210\n10.1155/2023/8307249\n10.1007/s00404-017-4485-7\n10.13422/j.cnki.syfjx.20201963\n10.19378/j.issn.1003-9783.2021.10.008\n10.1016/j.heliyon.2023.e20022\n10.1158/1055-9965.EPI-10-0565\n10.1007/s11064-020-03215-8\n10.1002/mas.21562\n10.1021/pr500886y\n10.1016/j.cbpa.2015.11.009\n10.3390/metabo8010014\n10.1007/s11255-023-03779-8\n10.1016/j.compbiomed.2022.105389\n10.3389/fphar.2022.952677\n10.1016/j.jep.2023.116847\n10.1016/j.jep.2022.115876\n10.1073/pnas.0506580102\n10.1016/j.brainresbull.2021.02.021\n10.3389/fphys.2022.935870\n10.1016/j.compbiomed.2022.105454\n10.1016/j.phrs.2021.106000\n10.1016/j.heliyon.2023.e14029\n10.1080/07853890.2023.2218105\n10.1177/20420188231187493\n10.1080/07853890.2022.2034931\n10.1186/s13020-022-00698-1\n10.1097/MD.0000000000023222\n10.1001/jama.2019.16921\n10.2165/00148581-200810010-00001\n10.1007/s11655-022-3319-z\n10.1080/01443615.2020.1820461\n10.1080/01443615.2022.2130208\n10.1371/journal.pone.0170952\n10.1182/blood.2022018667\n10.1016/j.jep.2020.113053\n10.1093/humupd/dmq016\n10.3390/nu12103012\n10.1016/j.ceca.2023.102716\n10.1262/jrd.2017-076\n10.1210/mend.12.6.0124\n10.1038/s41598-018-30094-5\n10.1038/nrendo.2011.122\n10.1016/j.jchromb.2021.122523\n10.3109/09513599509160464\n10.3390/ijms23116128\n10.1007/s00404-019-05343-1\n10.1084/jem.20182325\n10.1186/s13578-023-01002-w\n10.1016/j.ydbio.2016.01.032\n10.3390/ijms23179567\n10.1016/j.cytogfr.2015.07.014\n10.1016/j.expneurol.2018.06.013\n10.1152/ajpendo.00618.2012\n10.1093/humupd/4.5.565\n10.1074/jbc.270.41.24019\n10.1074/jbc.272.34.21565\n10.1074/jbc.M112.381202\n10.1136/thorax-2021-218360\n10.1161/01.RES.0000036753.50601.E9\n10.1093/molehr/8.6.552\n10.1371/journal.pone.0252438\n10.1080/09513590.2021.1879784\n10.1038/s41598-023-27575-7\n10.1017/S0967199422000399\n10.1093/molehr/gax057\n10.1093/molehr/gat015\n10.1074/jbc.M112.388785\n10.1080/10495398.2023.2174875\n10.1016/j.ejphar.2023.175494",
    "journal": "Current pharmaceutical design",
    "keywords": [
        "Primary dysmenorrhea",
        "Wenjing Huoxue decoction",
        "ibuprofen.",
        "metabonomics",
        "metwork pharmacology",
        "transcriptomics"
    ],
    "methods": null,
    "publication_date": "2024-05-27",
    "pubmed_id": "38798215\n30306525\n33030880\n28292449\n36647866\n26346058\n28888592\n35856377\n36852393\n28791471\n37809621\n20805315\n33586092\n29486047\n25411686\n26673825\n29438325\n37728808\n36160389\n37356743\n16199517\n33631271\n36171972\n35367781\n34838694\n36911881\n37318081\n37780174\n35132912\n36566207\n33217837\n31855238\n18162003\n35426052\n33228406\n36227618\n28170396\n36574346\n32534120\n20551073\n33008039\n36931194\n29276208\n9626653\n30076382\n21844907\n33497845\n8629459\n35682815\n18296341\n31734759\n31645367\n36944972\n26896591\n36076964\n26198769\n29940159\n7254732\n23757407\n10027610\n7592599\n9261177\n22942274\n36283827\n12364394\n12029073\n34270573\n33525940\n36781904\n36683392\n29121349\n23475986\n22815484\n36794322\n36657656",
    "results": "WJHXD has been found to be effective in prolonging the onset time and decreasing the number of writhing episodes in PD rats after oxytocin injection. It has also been observed to reduce the levels of PGF2, COX-2, AVP, and PGE2 in the serum of PD rats to different degrees. Transcriptomics analysis has revealed that the core targets of WJHXD include KRT1, KRT16, CCL5, F2, NOS2, RAC2, and others, while the core pathways are Calcium signaling and cAMP signaling. The Estrogen signaling pathway was found to be downregulated in PD rats compared to normal uterine tissue, but WJHXD was able to up-regulate the pathway. A combined transcriptomics and metabolomics analysis suggested that WJHXD may be involved in eight metabolism-related pathways, with the most reliable ones being mucin-type O-glycan biosynthesis and glycolysis or gluconeogenesis. MD has shown that Hydroxyisocaproic acid may bind to important targets such as SLC6A4, PTGER3, IGFBP3, and IGF2.",
    "title": "Examining the Mechanism of Treatment for Primary Dysmenorrhea with Wenjing Huoxue Decoction based on Transcriptomics, Metabolomics, and Network Pharmacology.",
    "xml": "<Element 'PubmedArticle' at 0x788506e7e7f0>"
}